Skip to main content
. 2021 Jun 9;157(7):874–876. doi: 10.1001/jamadermatol.2021.1850

Table 1. Characteristics of Young Adult Survivors of Melanoma by Annual PSE Status in the Prior Yeara.

Characteristic No. (%) P valuec
All PSE statusb
Yes No
Total 128 75 46 NA
Age at diagnosis, y .10
<20 46 (36) 23 (31) 21 (46)
20-24 82 (64) 52 (69) 25 (54)
Sex .23
Female 78 (61) 49 (65) 25 (54)
Male 50 (39) 26 (35) 21 (46)
Race/ethnicity .02
Non-Hispanic White 107 (84) 69 (92) 34 (74)
Hispanic 13 (10) 3 (4) 9 (20)
Other 8 (6) 3 (4) 3 (7)
Socioeconomic status .03
Low/low-middle 23 (18) 8 (11) 13 (28)
Middle 28 (22) 17 (23) 11 (24)
Higher-middle/high 77 (60) 50 (67) 22 (48)
Melanoma stage at diagnosis .96
I (localized) 111 (87) 65 (87) 40 (87)
≥II (regional, distant) or unknown 17 (13) 10 (13) 6 (13)
Years since diagnosis .67
5-9 39 (30) 24 (32) 14 (30)
10-14 62 (48) 38 (51) 21 (46)
15-19 27 (21) 13 (17) 11 (24)
Usual source of melanoma-related care .01
Dermatologist 23 (19) 17 (23) 6 (13)
Oncologist (pediatric or medical) 64 (53) 45 (60) 19 (41)
Other/not sure/missing 34 (28) 13 (17) 21 (46)

Abbreviations: NA, not applicable; PSE, physician-based skin examinations.

a

Participants were diagnosed with stage 1 or higher melanoma at 24 years or younger in 1996 to 2004 in Los Angeles County and were 18 to 39 years old and 5 or more years postdiagnosis at time of survey in 2015.

b

Seven participants were missing information on PSE status.

c

As determined by χ2 test.